title: A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chernobyl fallout.
abstract: BACKGROUND
  Like stable iodine, radioiodines concentrate in the thyroid gland, increasing thyroid cancer risk in exposed children. Data on exposure to the embryonic/fetal thyroid are rare, raising questions about use of iodine 131 (I-131) in pregnant women. We present here estimated risks of thyroid disease from exposure in utero to I-131 fallout from the Chernobyl nuclear accident.
  
  
  METHODS
  We conducted a cross-sectional thyroid screening study (palpation, ultrasound, thyroid hormones, and, if indicated, fine needle aspiration) from 2003 to 2006. Participants were 2582 mother-child pairs from Ukraine in which the mother had been pregnant at the time of the accident on April 26, 1986, or 2 months after the time during which I-131 fallout was still present (1494 from contaminated areas, 1088 in the comparison group). Individual cumulative in utero thyroid dose estimates were derived from estimated I-131 activity in the mother's thyroid (mean 72 mGy; range 0-3230 mGy).
  
  
  RESULTS
  There were seven cases of thyroid carcinoma and one case of Hurthle cell neoplasm identified as a result of the screening. Whereas the estimated excess odds ratio per gray for thyroid carcinoma was elevated (excess odds ratio per gray 11.66), it was not statistically significant (P = 0.12). No radiation risks were identified for other thyroid diseases.
  
  
  CONCLUSIONS
  Our results suggest that in utero exposure to radioiodines may have increased the risk of thyroid carcinoma approximately 20 yr after the Chernobyl accident, supporting a conservative approach to medical uses of I-131 during pregnancy.
authors.affiliation: Chernobyl Research Unit, Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, EPS 7098, Rockville, Maryland 20852, USA. hatchm@mail.nih.gov
authors.forename: M
authors.initials: M
authors.lastname: Hatch
authors.forename: A
authors.initials: A
authors.lastname: Brenner
authors.forename: T
authors.initials: T
authors.lastname: Bogdanova
authors.forename: A
authors.initials: A
authors.lastname: Derevyanko
authors.forename: N
authors.initials: N
authors.lastname: Kuptsova
authors.forename: I
authors.initials: I
authors.lastname: Likhtarev
authors.forename: A
authors.initials: A
authors.lastname: Bouville
authors.forename: V
authors.initials: V
authors.lastname: Tereshchenko
authors.forename: L
authors.initials: L
authors.lastname: Kovgan
authors.forename: V
authors.initials: V
authors.lastname: Shpak
authors.forename: E
authors.initials: E
authors.lastname: Ostroumova
authors.forename: E
authors.initials: E
authors.lastname: Greenebaum
authors.forename: L
authors.initials: L
authors.lastname: Zablotska
authors.forename: E
authors.initials: E
authors.lastname: Ron
authors.forename: M
authors.initials: M
authors.lastname: Tronko
mesh_terms: D000293:Adolescent; D000328:Adult; D047852:Chernobyl Nuclear Accident; D003430:Cross-Sectional Studies; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005333:Fetus / Q000528:radiation effects*; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects*; D008297:Male; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D011247:Pregnancy; D011829:Radiation Dosage; D013959:Thyroid Diseases / Q000209:etiology*; D013964:Thyroid Neoplasms / Q000209:etiology*
chemical_list: D007457:Iodine Radioisotopes